BBVA USA’s CVS Health CVS Stock Holding History

BBVA USA’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.69M	Sell	19,894 -13	-0.1%	-$1.09K	0.1%	199
2021 Q2	$1.66M	Buy	+19,907	New	+$1.63M	0.09%	206

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBVA USA's CVS Position: Q3 2021 in Review

BBVA USA reduced its CVS Health (CVS) stake by 0.07% in Q3 2021, selling an estimated $1.09K and leaving 19,894 shares worth $1.69M. The position accounts for 0.1% of the portfolio, ranked #199.

BBVA USA first reported a position in CVS in Q2 2021 and has held it in 2 quarters since. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

BBVA USA held 19,894 shares of CVS Health worth $1.69M as of Q3 2021.
BBVA USA sold 13 CVS Health shares in Q3 2021, an estimated $1.09K.
CVS Health made up 0.1% of BBVA USA's portfolio in Q3 2021, its #199 holding.
BBVA USA first reported a position in CVS Health in Q2 2021 and has held it in 2 quarters since.
2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.